The Science of Talent by BioTalent Canada
Accessing (and keeping) talent in today’s biotechnology sector isn’t easy. There’s no question that biotech, life sciences, and the medical field in general experienced massive acceleration since March 2020. More treatments have been approved, biotech investment reached record heights, and thousands of new companies entered the landscape, heralding unprecedented growth in just about every aspect of the sector – bio health, bioenergy, bio-industrial, and agri-bio.In this podcast, Rob Henderson, the CEO of BioTalent Canada, examines the latest labour market reports, labour market research, and shares success stories with other leaders in the biotech sector.It’s a fast moving, ever evolving field and finding and retaining the right people needs to be at the forefront.
The Science of Talent by BioTalent Canada
Commercializing the Academic Research – and Managing Substantial Growth
Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that.
Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model is working, with growth forecast to see 60 staff currently blossom to 150 in the next 18 months.
In addition, the Government of Canada recently made an $80.5 million investment in a key project API is involved in.
But that success itself brings many challenges. How is API handling those?
Guest: Andrew MacIsaac, CEO Applied Pharmaceutical Innovation (API)
Website: appliedpharma.ca
LinkedIn: https://www.linkedin.com/company/applied-pharmaceutical-innovation
Twitter: @api_applied
